MCB Try JB online
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chadli, A.
Right arrow Articles by Toft, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chadli, A.
Right arrow Articles by Toft, D.
Molecular and Cellular Biology, March 2006, p. 1722-1730, Vol. 26, No. 5
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.5.1722-1730.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

GCUNC-45 Is a Novel Regulator for the Progesterone Receptor/hsp90 Chaperoning Pathway

Ahmed Chadli,1,{dagger} J. Dinny Graham,2,{dagger},{ddagger} M. Greg Abel,2 Twila A. Jackson,2 David F. Gordon,2 William M. Wood,2 Sara J. Felts,1 Kathryn B. Horwitz,2 and David Toft1*

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota,1 Division of Endocrinology, Department of Medicine, University of Colorado Health Science Center, Denver, Colorado2

Received 13 September 2005/ Returned for modification 9 October 2005/ Accepted 19 December 2005

The hsp90 chaperoning pathway is a multiprotein system that is required for the production or activation of many cell regulatory proteins, including the progesterone receptor (PR). We report here the identity of GCUNC-45 as a novel modulator of PR chaperoning by hsp90. GCUNC-45, previously implicated in the activities of myosins, can interact in vivo and in vitro with both PR-A and PR-B and with hsp90. Overexpression and knockdown experiments show GCUNC-45 to be a positive factor in promoting PR function in the cell. GCUNC-45 binds to the ATP-binding domain of hsp90 to prevent the activation of its ATPase activity by the cochaperone Aha1. This effect limits PR chaperoning by hsp90, but this can be reversed by FKBP52, a cochaperone that is thought to act later in the pathway. These findings reveal a new cochaperone binding site near the N terminus of hsp90, add insight on the role of FKBP52, and identify GCUNC-45 as a novel regulator of the PR signaling pathway.


* Corresponding author. Mailing address: Mayo Clinic, 200 First St. Southwest, Rochester, MN 55905. Phone: (507) 284-8401. Fax: (507) 284-2053. E-mail: toft.david{at}mayo.edu.

{dagger} A.C. and J.D.G. contributed equally to this study.

{ddagger} Present address: Westmead Institute for Cancer Research, University of Sydney Westmead Hospital, Westmead, New South Wales, Australia.


Molecular and Cellular Biology, March 2006, p. 1722-1730, Vol. 26, No. 5
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.5.1722-1730.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2006 by the American Society for Microbiology. All rights reserved.